osthol has been researched along with Insulin Resistance in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeon, HJ; Jun, DW; Kim, EK; Lee, JS; Nam, HH; Saeed, WK | 1 |
| Qi, Z; Wang, H; Xie, M; Xue, J; Zhang, Y | 1 |
2 other study(ies) available for osthol and Insulin Resistance
| Article | Year |
|---|---|
Osthol attenuates hepatic steatosis via decreased triglyceride synthesis not by insulin resistance.
Topics: Animals; Biomarkers; Coumarins; Diet, High-Fat; Disease Models, Animal; Insulin Resistance; Liver; Non-alcoholic Fatty Liver Disease; Rats, Sprague-Dawley; Time Factors; Triglycerides | 2014 |
Osthole ameliorates insulin resistance by increment of adiponectin release in high-fat and high-sucrose-induced fatty liver rats.
Topics: Adiponectin; Animals; Blood Glucose; Cnidium; Coumarins; Dietary Fats; Dietary Sucrose; Fatty Liver; Fenofibrate; Hypoglycemic Agents; Hypolipidemic Agents; Inflammation; Insulin; Insulin Resistance; Lipids; Liver; Male; Peroxisome Proliferator-Activated Receptors; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2011 |